| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 2.62e-05 | 40 | 29 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 9.37e-05 | 61 | 29 | 3 | GO:0098632 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 1.60e-04 | 73 | 29 | 3 | GO:0044183 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 1.80e-04 | 76 | 29 | 3 | GO:0098631 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 2.11e-04 | 15 | 29 | 2 | GO:0004559 | |
| GeneOntologyMolecularFunction | mannosidase activity | 2.41e-04 | 16 | 29 | 2 | GO:0015923 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 7.95e-04 | 126 | 29 | 3 | GO:0051082 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 9.83e-04 | 32 | 29 | 2 | GO:0099186 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.56e-03 | 599 | 29 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 1.61e-03 | 161 | 29 | 3 | GO:0051087 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 1.67e-03 | 163 | 29 | 3 | GO:0031072 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.69e-03 | 42 | 29 | 2 | GO:0098918 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.99e-03 | 56 | 29 | 2 | GO:0016903 | |
| GeneOntologyBiologicalProcess | dendrite self-avoidance | 2.01e-06 | 18 | 29 | 3 | GO:0070593 | |
| GeneOntologyBiologicalProcess | protein refolding | 9.89e-06 | 30 | 29 | 3 | GO:0042026 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 1.59e-05 | 35 | 29 | 3 | GO:0051085 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 2.57e-05 | 41 | 29 | 3 | GO:0051084 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 3.64e-05 | 46 | 29 | 3 | GO:0006458 | |
| GeneOntologyBiologicalProcess | neuron recognition | 7.70e-05 | 59 | 29 | 3 | GO:0008038 | |
| GeneOntologyBiologicalProcess | chaperone-mediated protein folding | 1.91e-04 | 80 | 29 | 3 | GO:0061077 | |
| GeneOntologyBiologicalProcess | synapse organization | 3.24e-04 | 685 | 29 | 6 | GO:0050808 | |
| GeneOntologyCellularComponent | myelin sheath | 2.19e-04 | 217 | 29 | 4 | GO:0043209 | |
| Domain | - | 7.34e-07 | 12 | 29 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 7.34e-07 | 12 | 29 | 3 | IPR029047 | |
| Domain | - | 9.53e-07 | 13 | 29 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 9.53e-07 | 13 | 29 | 3 | IPR018181 | |
| Domain | HSP70_C | 9.53e-07 | 13 | 29 | 3 | IPR029048 | |
| Domain | HSP70 | 1.86e-06 | 16 | 29 | 3 | PF00012 | |
| Domain | HSP70_2 | 2.26e-06 | 17 | 29 | 3 | PS00329 | |
| Domain | HSP70_3 | 2.26e-06 | 17 | 29 | 3 | PS01036 | |
| Domain | HSP70_1 | 2.26e-06 | 17 | 29 | 3 | PS00297 | |
| Domain | Hsp_70_fam | 2.70e-06 | 18 | 29 | 3 | IPR013126 | |
| Domain | fn3 | 1.09e-04 | 162 | 29 | 4 | PF00041 | |
| Domain | FN3 | 1.82e-04 | 185 | 29 | 4 | SM00060 | |
| Domain | Ig_I-set | 2.02e-04 | 190 | 29 | 4 | IPR013098 | |
| Domain | ig | 2.02e-04 | 190 | 29 | 4 | PF00047 | |
| Domain | Immunoglobulin | 2.02e-04 | 190 | 29 | 4 | IPR013151 | |
| Domain | I-set | 2.02e-04 | 190 | 29 | 4 | PF07679 | |
| Domain | FN3 | 2.41e-04 | 199 | 29 | 4 | PS50853 | |
| Domain | FN3_dom | 2.91e-04 | 209 | 29 | 4 | IPR003961 | |
| Domain | IGc2 | 4.53e-04 | 235 | 29 | 4 | SM00408 | |
| Domain | Ig_sub2 | 4.53e-04 | 235 | 29 | 4 | IPR003598 | |
| Domain | UBA | 9.86e-04 | 30 | 29 | 2 | SM00165 | |
| Domain | UBA | 1.42e-03 | 36 | 29 | 2 | PF00627 | |
| Domain | UBA | 2.11e-03 | 44 | 29 | 2 | IPR015940 | |
| Domain | UBA | 2.41e-03 | 47 | 29 | 2 | PS50030 | |
| Domain | IG | 3.87e-03 | 421 | 29 | 4 | SM00409 | |
| Domain | Ig_sub | 3.87e-03 | 421 | 29 | 4 | IPR003599 | |
| Domain | UBA-like | 4.42e-03 | 64 | 29 | 2 | IPR009060 | |
| Domain | Ank | 5.19e-03 | 228 | 29 | 3 | PF00023 | |
| Domain | IG_LIKE | 6.65e-03 | 491 | 29 | 4 | PS50835 | |
| Domain | ANK | 6.77e-03 | 251 | 29 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 6.92e-03 | 253 | 29 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 7.00e-03 | 254 | 29 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 7.00e-03 | 254 | 29 | 3 | PS50297 | |
| Domain | Ig-like_dom | 7.24e-03 | 503 | 29 | 4 | IPR007110 | |
| Domain | Ankyrin_rpt | 7.62e-03 | 262 | 29 | 3 | IPR002110 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.23e-04 | 63 | 22 | 3 | M11187 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.76e-04 | 71 | 22 | 3 | M39690 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.91e-04 | 73 | 22 | 3 | MM14948 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.70e-04 | 82 | 22 | 3 | M27250 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.79e-04 | 92 | 22 | 3 | MM14951 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 4.98e-04 | 101 | 22 | 3 | M27253 | |
| Pubmed | 4.36e-08 | 9 | 29 | 3 | 21763498 | ||
| Pubmed | 6.23e-08 | 10 | 29 | 3 | 7906708 | ||
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 6.23e-08 | 10 | 29 | 3 | 11932435 | |
| Pubmed | 6.23e-08 | 10 | 29 | 3 | 12832005 | ||
| Pubmed | HIV-1 viral protein R (Vpr) and its interactions with host cell. | 1.14e-07 | 12 | 29 | 3 | 19275587 | |
| Pubmed | A role for Nr-CAM in the patterning of binocular visual pathways. | 1.14e-07 | 12 | 29 | 3 | 16701205 | |
| Pubmed | 1.38e-07 | 147 | 29 | 5 | 16959763 | ||
| Pubmed | Pioneering axons regulate neuronal polarization in the developing cerebral cortex. | 1.48e-07 | 13 | 29 | 3 | 24559674 | |
| Pubmed | 2.36e-07 | 15 | 29 | 3 | 10964507 | ||
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 2.90e-07 | 16 | 29 | 3 | 21738476 | |
| Pubmed | 6.40e-07 | 1285 | 29 | 9 | 35914814 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 16329989 | ||
| Pubmed | HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy. | 6.71e-07 | 2 | 29 | 2 | 34943954 | |
| Pubmed | Proteomic identification of the TRAF6 regulation of vacuolar ATPase for osteoclast function. | 6.86e-07 | 21 | 29 | 3 | 16196101 | |
| Pubmed | 1.18e-06 | 25 | 29 | 3 | 27483141 | ||
| Pubmed | 2.54e-06 | 32 | 29 | 3 | 12493773 | ||
| Pubmed | 2.83e-06 | 493 | 29 | 6 | 15368895 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 1838307 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 19659607 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 24491357 | ||
| Pubmed | Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. | 4.67e-06 | 39 | 29 | 3 | 25944111 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 27539848 | ||
| Pubmed | Interaction of amyloid precursor protein with contactins and NgCAM in the retinotectal system. | 6.70e-06 | 5 | 29 | 2 | 18272596 | |
| Pubmed | 8.69e-06 | 157 | 29 | 4 | 19423573 | ||
| Pubmed | 9.84e-06 | 162 | 29 | 4 | 25826454 | ||
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 1.00e-05 | 6 | 29 | 2 | 7988674 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 26546435 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 17184779 | ||
| Pubmed | 1.06e-05 | 51 | 29 | 3 | 36896912 | ||
| Pubmed | Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. | 1.26e-05 | 54 | 29 | 3 | 31792442 | |
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 34079090 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 23123197 | ||
| Pubmed | Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cells. | 1.41e-05 | 7 | 29 | 2 | 26823144 | |
| Pubmed | 1.82e-05 | 61 | 29 | 3 | 19875381 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 30591555 | ||
| Pubmed | 2.10e-05 | 64 | 29 | 3 | 36636478 | ||
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 7523108 | ||
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 8486356 | ||
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 38844137 | ||
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 19171884 | ||
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 23921388 | ||
| Pubmed | Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75. | 3.01e-05 | 10 | 29 | 2 | 30590033 | |
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 36427672 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 4.30e-05 | 477 | 29 | 5 | 31300519 | |
| Pubmed | Molecular interaction between HAX-1 and XIAP inhibits apoptosis. | 4.41e-05 | 12 | 29 | 2 | 20171186 | |
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 21965664 | ||
| Pubmed | 4.70e-05 | 486 | 29 | 5 | 20936779 | ||
| Pubmed | 5.13e-05 | 247 | 29 | 4 | 30713523 | ||
| Pubmed | UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. | 5.21e-05 | 13 | 29 | 2 | 27477512 | |
| Pubmed | 6.07e-05 | 14 | 29 | 2 | 22821687 | ||
| Pubmed | 6.07e-05 | 14 | 29 | 2 | 35677655 | ||
| Pubmed | TDRD3 promotes DHX9 chromatin recruitment and R-loop resolution. | 6.07e-05 | 14 | 29 | 2 | 34329467 | |
| Pubmed | 6.07e-05 | 14 | 29 | 2 | 19858219 | ||
| Pubmed | 6.23e-05 | 92 | 29 | 3 | 35530310 | ||
| Pubmed | 6.43e-05 | 93 | 29 | 3 | 22079093 | ||
| Pubmed | 6.64e-05 | 94 | 29 | 3 | 16325481 | ||
| Pubmed | A two-dimensional gel database of human colon carcinoma proteins. | 7.00e-05 | 15 | 29 | 2 | 9150948 | |
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 8892864 | ||
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 24368734 | ||
| Pubmed | 8.35e-05 | 549 | 29 | 5 | 38280479 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 8.68e-05 | 283 | 29 | 4 | 28533407 | |
| Pubmed | 9.06e-05 | 17 | 29 | 2 | 2355006 | ||
| Pubmed | Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage. | 9.06e-05 | 17 | 29 | 2 | 21825151 | |
| Pubmed | 9.06e-05 | 17 | 29 | 2 | 26180087 | ||
| Pubmed | 9.23e-05 | 105 | 29 | 3 | 23284306 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 9.29e-05 | 288 | 29 | 4 | 31501420 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 9.48e-05 | 564 | 29 | 5 | 21565611 | |
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 1.02e-04 | 18 | 29 | 2 | 17500065 | |
| Pubmed | Identification of FBXO25-interacting proteins using an integrated proteomics approach. | 1.12e-04 | 112 | 29 | 3 | 20473970 | |
| Pubmed | 1.14e-04 | 19 | 29 | 2 | 35173535 | ||
| Pubmed | 1.14e-04 | 19 | 29 | 2 | 38515377 | ||
| Pubmed | Identification of novel spartin-interactors shows spartin is a multifunctional protein. | 1.14e-04 | 19 | 29 | 2 | 19765186 | |
| Pubmed | 1.18e-04 | 591 | 29 | 5 | 15231748 | ||
| Pubmed | 1.22e-04 | 963 | 29 | 6 | 28671696 | ||
| Pubmed | 1.26e-04 | 20 | 29 | 2 | 19047629 | ||
| Pubmed | 1.26e-04 | 20 | 29 | 2 | 12560567 | ||
| Pubmed | 1.27e-04 | 117 | 29 | 3 | 18977241 | ||
| Pubmed | 1.34e-04 | 119 | 29 | 3 | 17601350 | ||
| Pubmed | 1.35e-04 | 608 | 29 | 5 | 16713569 | ||
| Pubmed | 1.38e-04 | 1431 | 29 | 7 | 37142655 | ||
| Pubmed | 1.43e-04 | 322 | 29 | 4 | 26514267 | ||
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 8673525 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 1.53e-04 | 22 | 29 | 2 | 26886794 | |
| Pubmed | NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity. | 1.53e-04 | 22 | 29 | 2 | 38303107 | |
| Pubmed | Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation. | 1.53e-04 | 22 | 29 | 2 | 9109416 | |
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 11530211 | ||
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 20111909 | ||
| Pubmed | 1.68e-04 | 23 | 29 | 2 | 1736542 | ||
| Pubmed | 1.68e-04 | 23 | 29 | 2 | 8093218 | ||
| Pubmed | Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins. | 1.68e-04 | 23 | 29 | 2 | 3099781 | |
| Pubmed | Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. | 1.68e-04 | 23 | 29 | 2 | 3264072 | |
| Pubmed | 1.83e-04 | 24 | 29 | 2 | 30719818 | ||
| Pubmed | 1.83e-04 | 24 | 29 | 2 | 10617616 | ||
| Pubmed | 1.94e-04 | 1049 | 29 | 6 | 27880917 | ||
| Pubmed | Biosensor-based micro-affinity purification for the proteomic analysis of protein complexes. | 1.99e-04 | 25 | 29 | 2 | 16212417 | |
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 1.99e-04 | 25 | 29 | 2 | 2283726 | |
| Pubmed | 1.99e-04 | 25 | 29 | 2 | 20019329 | ||
| Pubmed | Proteomic analysis of the NOS2 interactome in human airway epithelial cells. | 2.07e-04 | 138 | 29 | 3 | 23438482 | |
| Pubmed | 2.15e-04 | 26 | 29 | 2 | 26735018 | ||
| Pubmed | 2.15e-04 | 26 | 29 | 2 | 8218172 | ||
| Interaction | KISS1 interactions | 1.80e-06 | 17 | 29 | 3 | int:KISS1 | |
| Interaction | GSTM3 interactions | 2.06e-06 | 148 | 29 | 5 | int:GSTM3 | |
| Interaction | DNAJA1 interactions | 8.19e-06 | 533 | 29 | 7 | int:DNAJA1 | |
| Interaction | CSN1S1 interactions | 1.70e-05 | 35 | 29 | 3 | int:CSN1S1 | |
| Interaction | METTL21A interactions | 1.85e-05 | 36 | 29 | 3 | int:METTL21A | |
| Interaction | CLU interactions | 2.38e-05 | 245 | 29 | 5 | int:CLU | |
| Interaction | LCT interactions | 2.99e-05 | 6 | 29 | 2 | int:LCT | |
| Interaction | C2orf42 interactions | 5.57e-05 | 8 | 29 | 2 | int:C2orf42 | |
| Interaction | DNAJB1 interactions | 5.97e-05 | 297 | 29 | 5 | int:DNAJB1 | |
| Interaction | CPEB4 interactions | 7.06e-05 | 156 | 29 | 4 | int:CPEB4 | |
| Interaction | LY6G6D interactions | 7.15e-05 | 9 | 29 | 2 | int:LY6G6D | |
| Interaction | CEP57 interactions | 8.77e-05 | 165 | 29 | 4 | int:CEP57 | |
| Interaction | DPEP3 interactions | 8.93e-05 | 10 | 29 | 2 | int:DPEP3 | |
| Interaction | ALKBH3 interactions | 9.12e-05 | 61 | 29 | 3 | int:ALKBH3 | |
| Interaction | LIME1 interactions | 1.00e-04 | 63 | 29 | 3 | int:LIME1 | |
| Interaction | GPX7 interactions | 1.21e-04 | 67 | 29 | 3 | int:GPX7 | |
| Interaction | TNFRSF18 interactions | 1.31e-04 | 12 | 29 | 2 | int:TNFRSF18 | |
| Interaction | ANXA7 interactions | 1.34e-04 | 184 | 29 | 4 | int:ANXA7 | |
| Interaction | PCYT1B interactions | 1.54e-04 | 13 | 29 | 2 | int:PCYT1B | |
| Interaction | KCNMA1 interactions | 1.70e-04 | 196 | 29 | 4 | int:KCNMA1 | |
| Interaction | FBXO25 interactions | 1.77e-04 | 198 | 29 | 4 | int:FBXO25 | |
| Interaction | DDOST interactions | 1.79e-04 | 375 | 29 | 5 | int:DDOST | |
| Interaction | CDKN1A interactions | 1.79e-04 | 375 | 29 | 5 | int:CDKN1A | |
| Interaction | TCN2 interactions | 2.37e-04 | 16 | 29 | 2 | int:TCN2 | |
| Interaction | MEX3B interactions | 2.74e-04 | 222 | 29 | 4 | int:MEX3B | |
| Interaction | S100A2 interactions | 2.76e-04 | 412 | 29 | 5 | int:S100A2 | |
| Interaction | BAG4 interactions | 2.84e-04 | 224 | 29 | 4 | int:BAG4 | |
| Interaction | PRAP1 interactions | 3.02e-04 | 18 | 29 | 2 | int:PRAP1 | |
| Interaction | ZSWIM7 interactions | 3.02e-04 | 18 | 29 | 2 | int:ZSWIM7 | |
| Interaction | ATP1B3 interactions | 3.19e-04 | 231 | 29 | 4 | int:ATP1B3 | |
| Interaction | NPHP4 interactions | 3.46e-04 | 236 | 29 | 4 | int:NPHP4 | |
| Interaction | KCTD5 interactions | 3.61e-04 | 97 | 29 | 3 | int:KCTD5 | |
| Interaction | MTMR6 interactions | 3.61e-04 | 97 | 29 | 3 | int:MTMR6 | |
| Interaction | INVS interactions | 3.83e-04 | 99 | 29 | 3 | int:INVS | |
| Interaction | ZNF488 interactions | 4.13e-04 | 21 | 29 | 2 | int:ZNF488 | |
| Interaction | EGFL6 interactions | 4.13e-04 | 21 | 29 | 2 | int:EGFL6 | |
| Interaction | HSPA4L interactions | 4.30e-04 | 250 | 29 | 4 | int:HSPA4L | |
| Interaction | ICAM1 interactions | 4.43e-04 | 252 | 29 | 4 | int:ICAM1 | |
| Interaction | FBXL4 interactions | 4.68e-04 | 106 | 29 | 3 | int:FBXL4 | |
| Interaction | CIAO2B interactions | 4.81e-04 | 107 | 29 | 3 | int:CIAO2B | |
| Interaction | C6orf15 interactions | 4.96e-04 | 23 | 29 | 2 | int:C6orf15 | |
| Interaction | MATN4 interactions | 4.96e-04 | 23 | 29 | 2 | int:MATN4 | |
| Interaction | GHRL interactions | 5.41e-04 | 24 | 29 | 2 | int:GHRL | |
| Interaction | ADRM1 interactions | 5.43e-04 | 266 | 29 | 4 | int:ADRM1 | |
| Interaction | ATXN1 interactions | 5.45e-04 | 1039 | 29 | 7 | int:ATXN1 | |
| Interaction | DNASE1L2 interactions | 5.88e-04 | 25 | 29 | 2 | int:DNASE1L2 | |
| Interaction | TIA1 interactions | 6.16e-04 | 275 | 29 | 4 | int:TIA1 | |
| GeneFamily | Heat shock 70kDa proteins | 1.05e-06 | 17 | 22 | 3 | 583 | |
| GeneFamily | Fibronectin type III domain containing | 3.82e-05 | 160 | 22 | 4 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.91e-05 | 161 | 22 | 4 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 7.92e-05 | 193 | 22 | 4 | 594 | |
| GeneFamily | Ankyrin repeat domain containing | 3.02e-03 | 242 | 22 | 3 | 403 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.25e-06 | 200 | 29 | 4 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-04 | 164 | 29 | 3 | d7053de88ef8e42cac6726a40e72f212659ee034 | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.68e-04 | 166 | 29 | 3 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 167 | 29 | 3 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 167 | 29 | 3 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-04 | 169 | 29 | 3 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 1.80e-04 | 170 | 29 | 3 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-04 | 174 | 29 | 3 | 9d22a554617a93701d0945de63cc3e7b24322c40 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.96e-04 | 175 | 29 | 3 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 176 | 29 | 3 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-04 | 177 | 29 | 3 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.13e-04 | 180 | 29 | 3 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 181 | 29 | 3 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 183 | 29 | 3 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 183 | 29 | 3 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 183 | 29 | 3 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-04 | 183 | 29 | 3 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 183 | 29 | 3 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 183 | 29 | 3 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 184 | 29 | 3 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 184 | 29 | 3 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 184 | 29 | 3 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.31e-04 | 185 | 29 | 3 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.31e-04 | 185 | 29 | 3 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.31e-04 | 185 | 29 | 3 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 185 | 29 | 3 | 872720275789d249c9859de825a923803d458875 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-04 | 186 | 29 | 3 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-04 | 186 | 29 | 3 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 186 | 29 | 3 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 187 | 29 | 3 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 187 | 29 | 3 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.38e-04 | 187 | 29 | 3 | 1aebf6fab40b96f2f5feb77a302bb805838fccf3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-04 | 188 | 29 | 3 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-04 | 188 | 29 | 3 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-04 | 188 | 29 | 3 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.42e-04 | 188 | 29 | 3 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 2.42e-04 | 188 | 29 | 3 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-04 | 189 | 29 | 3 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-04 | 189 | 29 | 3 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 190 | 29 | 3 | 92710caaff05123cf8e909319d7ac441d9b31a66 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-04 | 190 | 29 | 3 | 396b7225c2430db3dc55a3d0db70239b71987229 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-04 | 191 | 29 | 3 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.54e-04 | 191 | 29 | 3 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.58e-04 | 192 | 29 | 3 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.58e-04 | 192 | 29 | 3 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.62e-04 | 193 | 29 | 3 | 9a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.62e-04 | 193 | 29 | 3 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.62e-04 | 193 | 29 | 3 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.62e-04 | 193 | 29 | 3 | 7c7aa5e2124830d0fa1df11b6413ec6cf780aad0 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 194 | 29 | 3 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.66e-04 | 194 | 29 | 3 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | facs-Heart-LA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 196 | 29 | 3 | 8a84aeb1a565dd3e2a690fcaf1ab804f5e253545 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.74e-04 | 196 | 29 | 3 | 40cae477b3906623d1f2a4c630279e710499ce80 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-04 | 196 | 29 | 3 | 37a5f9f3988778655580bd0383811bb4930c1551 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-04 | 196 | 29 | 3 | 77feb22fd0b0b1df03375da472134412e9e69c90 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 196 | 29 | 3 | d74e899cc120146dded3a20716e22c7aca4f074a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 196 | 29 | 3 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 197 | 29 | 3 | 4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.78e-04 | 197 | 29 | 3 | da653dc7d216e202f390e5ab0245f243e3ed213b | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.78e-04 | 197 | 29 | 3 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.78e-04 | 197 | 29 | 3 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.78e-04 | 197 | 29 | 3 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 197 | 29 | 3 | 02cc9d39afefa5e5b6f5d93f9adc3a20050b70dd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 198 | 29 | 3 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 198 | 29 | 3 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-04 | 198 | 29 | 3 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| ToppCell | 3'-GW_trimst-2|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-04 | 198 | 29 | 3 | cf9861bc14737f2dc72e50222159e0180a6d3e5c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 198 | 29 | 3 | 43a2ce64fa309bac89a44ea320e87ae2cc39f782 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-04 | 198 | 29 | 3 | 4448d13511485a44fe7b549e4b8b6ad7637db624 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.86e-04 | 199 | 29 | 3 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | distal-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.86e-04 | 199 | 29 | 3 | af226a6c50747dad9ca696463e715913b3ac17c0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-04 | 199 | 29 | 3 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.90e-04 | 200 | 29 | 3 | f09eaa52e11262ec47f3dcb4d890e240eaaa2b3d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-04 | 200 | 29 | 3 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-04 | 200 | 29 | 3 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-04 | 200 | 29 | 3 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-04 | 200 | 29 | 3 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-04 | 200 | 29 | 3 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-04 | 200 | 29 | 3 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 200 | 29 | 3 | 87c453bb3fa35fff6417dce1f9b08a335fd1546d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Macroglial-Glia_progenitor_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.90e-04 | 200 | 29 | 3 | fc9e2094f4d22412e3dd79e79649a6d46d62caec | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-04 | 200 | 29 | 3 | 829978708463a7459fe1041bd90196775bc4b531 | |
| Disease | psoriatic arthritis, psoriasis | 1.40e-05 | 6 | 29 | 2 | EFO_0000676, EFO_0003778 | |
| Disease | Myocardial Ischemia | 2.59e-05 | 176 | 29 | 4 | C0151744 | |
| Disease | digestive system infectious disorder | 2.99e-04 | 26 | 29 | 2 | MONDO_0043424 | |
| Disease | metastasis measurement, disease progression measurement | 5.13e-04 | 34 | 29 | 2 | EFO_0007675, EFO_0008336 | |
| Disease | high grade glioma (is_marker_for) | 7.84e-04 | 42 | 29 | 2 | DOID:3070 (is_marker_for) | |
| Disease | schizophrenia, anorexia nervosa | 1.02e-03 | 48 | 29 | 2 | MONDO_0005090, MONDO_0005351 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.25e-03 | 53 | 29 | 2 | C4707243 | |
| Disease | Liver carcinoma | 1.45e-03 | 507 | 29 | 4 | C2239176 | |
| Disease | Schizophrenia | 1.55e-03 | 883 | 29 | 5 | C0036341 | |
| Disease | rheumatoid arthritis (is_marker_for) | 2.10e-03 | 69 | 29 | 2 | DOID:7148 (is_marker_for) | |
| Disease | bipolar disorder | 2.33e-03 | 577 | 29 | 4 | MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LAPGPIPQVVEPIGV | 606 | Q68DN1 | |
| LIVRGPPGPPEAVTI | 591 | Q8IWV2 | |
| GRPPLPVPAVGIGTV | 891 | Q96HY7 | |
| GIEIGKVPPPIPGVG | 441 | Q96KQ4 | |
| VRPGVLPLTQPVGPI | 396 | Q6IQ32 | |
| LVRGPPGPPGIVIVE | 666 | O94779 | |
| VPVPVAPAVPPRGGT | 76 | Q96SQ7 | |
| VPPVPGNILPPEVRG | 296 | Q6ZW49 | |
| VGQVGVNVPIPVPLP | 466 | Q02252 | |
| QGPIVPAPVKGEGPI | 606 | Q96JE9 | |
| GIPPAPRGVPQIEVT | 466 | P54652 | |
| APVPGPVPVVGLGSL | 151 | Q99956 | |
| GVLPVVGVVRPAPPP | 2241 | Q9UMN6 | |
| IGIPPAPRGVPQIEV | 506 | P38646 | |
| RGPPPGIVPENGLVR | 651 | Q96PV7 | |
| PPGLVIPRPGTGITI | 341 | P29400 | |
| TVLVRGPPGPPGGVV | 601 | Q02246 | |
| PPGGPIITVHPKEIR | 986 | Q9Y2E5 | |
| LPPVPIPNLVGIRGG | 156 | O60476 | |
| GIPPAPRGVPQIEVT | 486 | P11021 | |
| VPGVGVPGAGIPVVP | 341 | P15502 | |
| VPGAGIPVVPGAGIP | 346 | P15502 | |
| IPVVPGAGIPGAAVP | 351 | P15502 | |
| GLPPEVREPGPGVEL | 6 | Q6NXP2 | |
| RIGPIKPAGPVTAVP | 506 | Q9H7E2 | |
| VAGGPVAVEPEVPPV | 1811 | Q9Y566 | |
| PPPPGGVGLGIRTVR | 31 | Q8IWZ3 | |
| PPVSPVGAEGPVVLR | 2356 | O15020 | |
| PVVVVTQPGVGPGPA | 6 | Q9NZF1 | |
| PVGPVTPIGPIGPIV | 491 | Q9UHD9 | |
| GLNGTKPVPPIPRGI | 906 | Q9Y4F4 | |
| PGGWEVLAVVVPVPP | 266 | Q06418 |